LONDON (Reuters) – AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after …
AstraZeneca Investing $2.5 Billion in China as Drugmaker Seeks to Recover From Scandals
view original post